BACKGROUND: Autogenous bone grafts from the iliac crest are frequently harvested for autologous bone transplantation. Although an autologous bone transplant does improve the local bone healing potency, significant donor site morbidity must be considered. METHODS: In this study we elucidate special bone harvesting techniques from the iliac crest and review the literature related to clinical significance of donor site morbidity. Furthermore, our own experiences are compared and discussed critically with relevant data of other investigators. RESULTS: The increasing number of scientific publications which focus on bone harvesting techniques and related complications in recent years indicate the high interest and relevance of this issue. There is a tendency to alternatives such as biomaterials as bone substitutes, whereas the role of growth factors and cell therapeutics in the treatment of bony defects are still being evaluated in clinical studies. CONCLUSION: Although autologous, heterotopic bone transplantation is still the gold standard in the treatment of bony defects, there is a tendency towards the application of biomaterials, stem cells, and growth factors. Conscientious observation of relevant anatomic considerations during bone harvesting procedures may help to avoid complications.
BACKGROUND: Autogenous bone grafts from the iliac crest are frequently harvested for autologous bone transplantation. Although an autologous bone transplant does improve the local bone healing potency, significant donor site morbidity must be considered. METHODS: In this study we elucidate special bone harvesting techniques from the iliac crest and review the literature related to clinical significance of donor site morbidity. Furthermore, our own experiences are compared and discussed critically with relevant data of other investigators. RESULTS: The increasing number of scientific publications which focus on bone harvesting techniques and related complications in recent years indicate the high interest and relevance of this issue. There is a tendency to alternatives such as biomaterials as bone substitutes, whereas the role of growth factors and cell therapeutics in the treatment of bony defects are still being evaluated in clinical studies. CONCLUSION: Although autologous, heterotopic bone transplantation is still the gold standard in the treatment of bony defects, there is a tendency towards the application of biomaterials, stem cells, and growth factors. Conscientious observation of relevant anatomic considerations during bone harvesting procedures may help to avoid complications.
Authors: George K B Sàndor; Brian N Rittenberg; Cameron M L Clokie; Marco F Caminiti Journal: J Oral Maxillofac Surg Date: 2003-02 Impact factor: 1.895
Authors: Steven A Zijderveld; Christiaan M ten Bruggenkate; Johan P A van Den Bergh; Egbert A J M Schulten Journal: J Oral Maxillofac Surg Date: 2004-07 Impact factor: 1.895
Authors: Stephan Reppenhagen; Johannes C Reichert; Lars Rackwitz; Maximilian Rudert; Peter Raab; Guy Daculsi; Ulrich Nöth Journal: Int Orthop Date: 2011-05-28 Impact factor: 3.075
Authors: James C Ferguson; Stefan Tangl; Dirk Barnewitz; Antje Genzel; Patrick Heimel; Veronika Hruschka; Heinz Redl; Thomas Nau Journal: BMC Vet Res Date: 2018-11-06 Impact factor: 2.741